
Younger individuals and those with specific sickle cell genotypes led to earlier predictions for fetal risk of sickle cell disease.
Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

Younger individuals and those with specific sickle cell genotypes led to earlier predictions for fetal risk of sickle cell disease.

Many gastroenterologists have utilized telemedicine during the ongoing COVID-19 pandemic.

The plan, developed in 2016, has resulted in reductions of most oral antibiotic uses, for both in-hospital and out-of-hospital settings.

Lamotrigine is currently being used as a maintenance therapy for bipolar disorder.

Small molecule treatments have been historically effective at treating IBD.

Viloxazine was approved in April by the FDA for pediatric ADHD patients between 6-17 years old.

There was no significant difference in performance between the model with only bile acids compared to models with bile acids and clinical variables.

Suspected suicide attempts have increased more among females.

Baseline eGFR and increasing age were good predictors of eGFR.

Sustained virologic response following direct acting antiviral treatment substantially reduced the all-cause mortality rate in patients with HCV.

More than half of the patients in the study were treated for inflammatory bowel disease with infliximab.

Patients included in the study had a median of 3 prior CDI episodes and 4 risk factors for recurrent infections.

REL-1017 was more effective when administered earlier rather than later.

Elexacaftor/tezacaftor/ivacaftor and ivacaftor was previously approved for CF patients at least 12 years old.

The UNITI studies have shown ustekinumab is effective at inducing and maintaining clinical remission in Crohn’s disease patients.

Using both tests to screen for colorectal cancer was more effective than just using colonoscopies alone.

The higher levels of visits were mostly maintained throughout the pandemic.

Direct-acting antivirals has increased the need to treat children HCV patients before they begin to engage in dangerous behaviors.

Externalizing ADHD symptoms was linked to suicidality.

Vedolizumab treatment was associated with lower IMC recurrence rate after ICI resumption.

The reduction in heavy drinking in individuals between 18-25 years old is likely due to government restrictions on social gatherings.

A recommendation for all adults in the US to be screened for HCV has increased the need for treatment programs in urban areas.

Seres expects to move forward with plans for SER-109 as a novel treatment for CDI.

Researchers compare 9 commonly used thermal care interventions for reduced core body temperatures.

Greater symptoms of depression, anxiety, and ADHD were associated with less sleep.

More patients treated with risankizumab 360 mg achieved clinical remission than the induction-only control group.

Patients treated with ustekinumab had significantly more prior biologic use than patients treated with vedolizumab.

Secukinumab is the only fully human biologic that directly inhibits IL-17A.

New research sheds light on the relationship between sleep timing and the risk of developing major depressive disorder (MDD).

The treatment is also being studied for safety and efficacy in patients with Crohn’s disease.